Biogenesis of tartrate-resistant acid phosphatase isoforms 5a and 5b in stably transfected MDA-MB-231 breast cancer epithelial cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 5, 2010, Pages 598-607

  Zenger, Serhan ^a   Ek Rylander, Barbro ^a   Andersson, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acp 5; Breast cancer; Cysteine proteinase; Macrophage; Osteoclast; Purple acid phosphatase; Tartrate resistant acid phosphatase; Uteroferrin

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME 5A; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME 5B; BREFELDIN A; CYSTEINE PROTEINASE INHIBITOR; CYSTEINE PROTEINASE INHIBITOR E64; ISOPROTEIN; MONOMER; UNCLASSIFIED DRUG;

ARTICLE; BIOGENESIS; BREAST CANCER; CANCER CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME RELEASE; EPITHELIUM CELL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GOLGI COMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION;

ACID PHOSPHATASE; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; BREFELDIN A; CHROMATOGRAPHY, AFFINITY; CONCANAVALIN A; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; ISOENZYMES; LECTINS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN SYNTHESIS INHIBITORS; RATS; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 77951937662     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.01.021     Document Type: Article

References (64)

1. Oddie G.W., Schenk G., Angel N.Z., Walsh N., Guddat L.W., de Jersey J., Cassady A.I., Hamilton S.E., Hume D.A. Structure, function, and regulation of tartrate-resistant acid phosphatase. Bone 2000, 27:575-584.
2. Janckila A.J., Yam L.T. Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme. Calcif. Tissue Int. 2009, 85:465-483.
3. Ek-Rylander B., Bill P., Norgard M., Nilsson S., Andersson G. Cloning, sequence, and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone. J. Biol. Chem. 1991, 266:24684-24689.
4. Ek-Rylander B., Barkhem T., Ljusberg J., Ohman L., Andersson K.K., Andersson G. Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase. Biochem. J. 1997, 321(Pt 2):305-311.
5. Funhoff E.G., Ljusberg J., Wang Y., Andersson G., Averill B.A. Mutational analysis of the interaction between active site residues and the loop region in mammalian purple acid phosphatases. Biochemistry 2001, 40:11614-11622.
6. Ljusberg J., Ek-Rylander B., Andersson G. Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases. Biochem. J. 1999, 343(Pt 1):63-69.
7. Ljusberg J., Wang Y., Lang P., Norgard M., Dodds R., Hultenby K., Ek-Rylander B., Andersson G. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J. Biol. Chem. 2005, 280:28370-28381.
8. Zenger S., Hollberg K., Ljusberg J., Norgard M., Ek-Rylander B., Kiviranta R., Andersson G. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice. Bone 2007, 41:820-832.
9. Angel N.Z., Walsh N., Forwood M.R., Ostrowski M.C., Cassady A.I., Hume D.A. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J. Bone Miner. Res. 2000, 15:103-110.
10. Hayman A.R., Bune A.J., Bradley J.R., Rashbass J., Cox T.M. Osteoclastic tartrate-resistant acid phosphatase (Acp 5): its localization to dendritic cells and diverse murine tissues. J. Histochem. Cytochem. 2000, 48:219-228.
11. Hayman A.R., Macary P., Lehner P.J., Cox T.M. Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells. J. Histochem. Cytochem. 2001, 49:675-684.
12. Lang P., Andersson G. Differential expression of monomeric and proteolytically processed forms of tartrate-resistant acid phosphatase in rat tissues. Cell. Mol. Life Sci. 2005, 62:905-918.
13. Lang P., Schultzberg M., Andersson G. Expression and distribution of tartrate-resistant purple acid phosphatase in the rat nervous system. J. Histochem. Cytochem. 2001, 49:379-396.
14. Adams L.M., Warburton M.J., Hayman A.R. Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase. Cell Biol. Int. 2007, 31:191-195.
15. Honig A., Rieger L., Kapp M., Krockenberger M., Eck M., Dietl J., Kammerer U. Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study. BMC Cancer 2006, 6:199.
16. Janckila A.J., Parthasarathy R.N., Parthasarathy L.K., Seelan R.S., Yam L.T. Stable expression of human tartrate-resistant acid phosphatase isoforms by CHO cells. Clin. Chim. Acta 2002, 326:113-122.
17. Janckila A.J., Takahashi K., Sun S.Z., Yam L.T. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin. Chem. 2001, 47:74-80.
18. Sheu T.J., Schwarz E.M., Martinez D.A., O'Keefe R.J., Rosier R.N., Zuscik M.J., Puzas J.E. A phage display technique identifies a novel regulator of cell differentiation. J. Biol. Chem. 2003, 278:438-443.
19. Lang P., van Harmelen V., Ryden M., Kaaman M., Parini P., Carneheim C., Cassady A.I., Hume D.A., Andersson G., Arner P. Monomeric tartrate resistant Acid phosphatase induces insulin sensitive obesity. PLoS ONE 2008, 3:e1713.
20. Ek-Rylander B., Flores M., Wendel M., Heinegard D., Andersson G. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J. Biol. Chem. 1994, 269:14853-14856.
21. Halleen J.M., Kaija H., Stepan J.J., Vihko P., Vaananen H.K. Studies on the protein tyrosine phosphatase activity of tartrate-resistant acid phosphatase. Arch. Biochem. Biophys. 1998, 352:97-102.
22. Halleen J.M., Raisanen S., Salo J.J., Reddy S.V., Roodman G.D., Hentunen T.A., Lehenkari P.P., Kaija H., Vihko P., Vaananen H.K. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J. Biol. Chem. 1999, 274:22907-22910.
23. Halleen J.M., Ylipahkala H., Alatalo S.L., Janckila A.J., Heikkinen J.E., Suominen H., Cheng S., Vaananen H.K. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif. Tissue Int. 2002, 71:20-25.
24. Alatalo S.L., Ivaska K.K., Waguespack S.G., Econs M.J., Vaananen H.K., Halleen J.M. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin. Chem. 2004, 50:883-890.
25. Rissanen J.P., Suominen M.I., Peng Z., Halleen J.M. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif. Tissue Int. 2008, 82:108-115.
26. Halleen J.M., Alatalo S.L., Janckila A.J., Woitge H.W., Seibel M.J., Vaananen H.K. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin. Chem. 2001, 47:597-600.
27. Halleen J.M., Alatalo S.L., Suominen H., Cheng S., Janckila A.J., Vaananen H.K. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J. Bone Miner. Res. 2000, 15:1337-1345.
28. Terpos E., de la Fuente J., Szydlo R., Hatjiharissi E., Viniou N., Meletis J., Yataganas X., Goldman J.M., Rahemtulla A. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Int. J. Cancer 2003, 106:455-457.
29. Nenonen A., Cheng S., Ivaska K.K., Alatalo S.L., Lehtimaki T., Schmidt-Gayk H., Uusi-Rasi K., Heinonen A., Kannus P., Sievanen H., Vuori I., Vaananen H.K., Halleen J.M. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. J. Bone Miner. Res. 2005, 20:1804-1812.
30. Hannon R.A., Clowes J.A., Eagleton A.C., Al Hadari A., Eastell R., Blumsohn A. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. Bone 2004, 34:187-194.
31. Gerdhem P., Ivaska K.K., Alatalo S.L., Halleen J.M., Hellman J., Isaksson A., Pettersson K., Vaananen H.K., Akesson K., Obrant K.J. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J. Bone Miner. Res. 2004, 19:386-393.
32. Wada N., Ishii S., Ikeda T., Enomoto K., Kitajima M. Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer. Anticancer Res. 1999, 19:4515-4521.
33. Sun P., Sleat D.E., Lecocq M., Hayman A.R., Jadot M., Lobel P. Acid phosphatase 5 is responsible for removing the mannose 6-phosphate recognition marker from lysosomal proteins. Proc. Natl. Acad. Sci. USA 2008, 105:16590-16595.
34. Ek-Rylander B., Andersson G. Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. Exp. Cell Res. 2010, 316:443-451.
35. Kamiya T., Kobayashi Y., Kanaoka K., Nakashima T., Kato Y., Mizuno A., Sakai H. Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. J. Biochem. (Tokyo) 1998, 123:752-759.
36. Igarashi Y., Lee M.Y., Matsuzaki S. Heparin column analysis of serum type 5 tartrate-resistant acid phosphatase isoforms. J. Chromatogr. 2001, 757:269-276.
37. Wang Y., Norgard M., Andersson G. N-glycosylation influences the latency and catalytic properties of mammalian purple acid phosphatase. Arch. Biochem. Biophys. 2005, 435:147-156.
38. Wang Y., Andersson G. Expression and proteolytic processing of mammalian purple acid phosphatase in CHO-K1 cells. Arch. Biochem. Biophys. 2007, 461:85-94.
39. Bossard M.J., Tomaszek T.A., Thompson S.K., Amegadzie B.Y., Hanning C.R., Jones C., Kurdyla J.T., McNulty D.E., Drake F.H., Gowen M., Levy M.A. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J. Biol. Chem. 1996, 271:12517-12524.
40. Filgueira L. Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols. J. Histochem. Cytochem. 2004, 52:411-414.
41. Raisanen S.R., Halleen J., Parikka V., Vaananen H.K. Tartrate-resistant acid phosphatase facilitates hydroxyl radical formation and colocalizes with phagocytosed Staphylococcus aureus in alveolar macrophages. Biochem. Biophys. Res. Commun. 2001, 288:142-150.
42. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3:97-130.
43. Sciaky N., Presley J., Smith C., Zaal K.J., Cole N., Moreira J.E., Terasaki M., Siggia E., Lippincott-Schwartz J. Golgi tubule traffic and the effects of brefeldin A visualized in living cells. J. Cell Biol. 1997, 139:1137-1155.
44. Perez-Amodio S., Jansen D.C., Tigchelaar-Gutter W., Beertsen W., Everts V. Endocytosis of tartrate-resistant acid phosphatase by osteoblast-like cells is followed by inactivation of the enzyme. Calcif. Tissue Int. 2006, 78:248-254.
45. Littlewood-Evans A.J., Bilbe G., Bowler W.B., Farley D., Wlodarski B., Kokubo T., Inaoka T., Sloane J., Evans D.B., Gallagher J.A. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 1997, 57:5386-5390.
46. Ishibashi O., Mori Y., Kurokawa T., Kumegawa M. Breast cancer cells express cathepsins B and L but not cathepsins K or H. Cancer Biochem. Biophys. 1999, 17:69-78.
47. Janckila A.J., Neustadt D.H., Nakasato Y.R., Halleen J.M., Hentunen T., Yam L.T. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis. Clin. Chim. Acta 2002, 320:49-58.
48. Janckila A.J., Parthasarathy R.N., Parthasarathy L.K., Seelan R.S., Hsueh Y.C., Rissanen J., Alatalo S.L., Halleen J.M., Yam L.T. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells. J. Leukoc. Biol. 2005, 77:209-218.
49. Janckila A.J., Slone S.P., Lear S.C., Martin A., Yam L.T. Tartrate-resistant acid phosphatase as an immunohistochemical marker for inflammatory macrophages. Am. J. Clin. Pathol. 2007, 127:556-566.
50. Vaaraniemi J., Halleen J.M., Kaarlonen K., Ylipahkala H., Alatalo S.L., Andersson G., Kaija H., Vihko P., Vaananen H.K. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J. Bone Miner. Res. 2004, 19:1432-1440.
51. Yasue H., Kusumoto H., Mikami H. Assignment of the uteroferrin gene (ACP5) to swine chromosome 2q12->q21 by fluorescence in situ hybridization. Cytogenet. Cell Genet. 1995, 71:249-252.
52. Grimes R., Reddy S.V., Leach R.J., Scarcez T., Roodman G.D., Sakaguchi A.Y., Lalley P.A., Windle J.J. Assignment of the mouse tartrate-resistant acid phosphatase gene (Acp5) to chromosome 9. Genomics 1993, 15:421-422.
53. Kawaguchi T., Nakano T., Sasagawa K., Ohashi T., Miura T., Komoda T. Tartrate-resistant acid phosphatase 5a and 5b contain distinct sugar moieties. Clin. Biochem. 2008, 41:1245-1249.
54. Baumbach G.A., Saunders P.T., Bazer F.W., Roberts R.M. Uteroferrin has N-asparagine-linked high-mannose-type oligosaccharides that contain mannose 6-phosphate. Proc. Natl. Acad. Sci. USA 1984, 81:2985-2989.
55. Baumbach G.A., Saunders P.T., Ketcham C.M., Bazer F.W., Roberts R.M. Uteroferrin contains complex and high mannose-type oligosaccharides when synthesized in vitro. Mol. Cell. Biochem. 1991, 105:107-117.
56. Leeming D.J., Koizumi M., Byrjalsen I., Li B., Qvist P., Tanko L.B. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients. Cancer Epidemiol. Biomarkers Prev. 2006, 15:32-38.
57. Voorzanger-Rousselot N., Juillet F., Mareau E., Zimmermann J., Kalebic T., Garnero P. Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation. Br. J. Cancer 2006, 95:506-514.
58. Chao T.Y., Yu J.C., Ku C.H., Chen M.M., Lee S.H., Janckila A.J., Yam L.T. Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients. Clin. Cancer Res. 2005, 11:544-550.
59. Chung Y.C., Ku C.H., Chao T.Y., Yu J.C., Chen M.M., Lee S.H. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment. Cancer Epidemiol. Biomarkers Prev. 2006, 15:424-428.
60. Perez-Amodio S., Vogels I.M., Schoenmaker T., Jansen D.C., Alatalo S.L., Halleen J.M., Beertsen W., Everts V. Endogenous expression and endocytosis of tartrate-resistant acid phosphatase (TRACP) by osteoblast-like cells. Bone 2005, 36:1065-1077.
61. Ishibashi O., Niwa S., Kadoyama K., Inui T. MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration. Life Sci. 2006, 79:1657-1660.
62. Montaser M., Lalmanach G., Mach L. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells. Biol. Chem. 2002, 383:1305-1308.
63. Gray A.W., Davies M.E., Jeffcott L.B. Localisation and activity of cathepsins K and B in equine osteoclasts. Res. Vet. Sci. 2002, 72:95-103.
64. Simpson K.J., Selfors L.M., Bui J., Reynolds A., Leake D., Khvorova A., Brugge J.S. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat. Cell Biol. 2008, 10:1027-1038.